The TP53 tumor suppressor and autophagy in malignant lymphoma

被引:13
|
作者
Xu-Monette, Zijun Y. [1 ]
Young, Ken H. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
autophagy; TP53; survival factor; prognosis; ULK1; EI24; SESN1; NUPR1; ERK; JNK;
D O I
10.4161/auto.19703
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The TP53 (p53) protein is a well-known tumor suppressor that plays a crucial role in maintaining genome stability under various cellular stresses. Loss of TP53 causes lymphomagenesis in mouse models and/or promotes tumor progression. However, the prognostic significance of TP53 has been inconsistent in human cancers including malignant lymphoma. In our recent review of TP53 dysfunction in lymphoid malignancies, we discussed the fact that the TP53 function in autophagy may be one of the important mechanisms responsible for the inconsistency of TP53 prognostic value, in that autophagy can promote survival of lymphoma cells by recycling toxic intracellular materials and inhibiting apoptosis. Here we discuss the biological mechanisms of TP53 functional switches from apoptosis to autophagy, and provide a brief summary of how TP53 regulates autophagy through its transcriptional activity on 14 genes of the TP53 pathway.
引用
收藏
页码:842 / 845
页数:4
相关论文
共 50 条
  • [21] Genetic and immunophenotype analyses of TP53 in bladder cancer -: TP53 alterations are associated with tumor progression
    Erill, N
    Colomer, A
    Verdú, M
    Román, R
    Condom, E
    Hannaoui, N
    Banús, JM
    Cordon-Cardo, C
    Puig, X
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2004, 13 (04) : 217 - 223
  • [22] TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells
    Wang, Haiwei
    Wang, Xinrui
    Xu, Liangpu
    Zhang, Ji
    FEBS OPEN BIO, 2022, 12 (03): : 616 - 626
  • [23] LACK OF MUTATIONS IN THE TP53 TUMOR SUPPRESSOR GENE EXONS 5 TO 8 IN FANCONI ANEMIA
    JONVEAUX, P
    LECONIAT, M
    GRAUSZ, D
    BERGER, R
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1991, 33 (05): : 343 - 345
  • [24] Detailed computational study of point mutations of the Tp53 tumor-suppressor protein.
    Pricl, S
    Fermeglia, M
    Ferrone, M
    Tamborini, E
    Pierotti, MA
    Pilotti, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U47 - U47
  • [25] The tumor suppressor gene TP53 - Twenty years (and 10,000 mutations) later
    Hainaut, P
    BULLETIN DU CANCER, 2000, 87 (01) : 11 - 18
  • [26] Mutations in TP53 tumor suppressor gene in wood dust-related sinonasal cancer
    Holmila, Reetta
    Bornholdt, Jette
    Heikkila, Pirjo
    Suitiala, Tuula
    Fevotte, Joelle
    Cyr, Diane
    Hansen, Johnni
    Snellman, Satu-Marja
    Dictor, Michael
    Steiniche, Torben
    Schlunssen, Vivi
    Schneider, Thomas
    Pukkala, Eero
    Savolainen, Kai
    Wolff, Henrik
    Wallin, Hakan
    Luce, Daniele
    Husgafvel-Pursiainen, Kirsti
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (03) : 578 - 588
  • [27] Analysis of TP53 mutations in human malignant gliomas
    Sylvia Norman
    Adrienne Scheck
    Jeff Braman
    Nature Genetics, 2001, 27 (Suppl 4) : 76 - 76
  • [28] TP53 MUTATIONS ARE FREQUENT IN MALIGNANT NFI TUMORS
    LEGIUS, E
    DIERICK, H
    WU, R
    HALL, BK
    MARYNEN, P
    CASSIMAN, JJ
    GLOVER, TW
    GENES CHROMOSOMES & CANCER, 1994, 10 (04): : 250 - 255
  • [29] Tumour suppressor genes and angiogenesis: The role of TP53 in fibroblasts
    Stellmach, V
    Volpert, OV
    Crawford, SE
    Lawler, J
    Hynes, RO
    Bouck, N
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) : 2394 - 2400
  • [30] The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
    Leroy, Bernard
    Fournier, Jean Louis
    Ishioka, Chikashi
    Monti, Paola
    Inga, Alberto
    Fronza, Gilberto
    Soussi, Thierry
    NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D962 - D969